Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zandberg

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Current Oncology (Toronto, Ont.)|October 27, 2023
Predictors and Consequences of Cancer and Non-Cancer-Related Pain in Those Diagnosed with Primary and Metastatic CancersKriti Shah, David A Geller, Samer Tohme, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 24, 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck SocietyKevin J Contrera, Sagar Kansara, Neerav Goyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid CancerMartina Chirra, Andrew Elliott, Hira Shaikh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck CancerDan P Zandberg, Lazar Vujanovic, David A Clump, et al.
Cancer Research Communications|March 2, 2023
Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay ValidationSophie Wildsmith, Jiabu Ye, April Franks, et al.
JCO Precision Oncology|November 20, 2024
CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A ReviewKevin J Contrera, Matthew E Spector, Liron Pantanowitz, et al.
Psycho-Oncology|January 27, 2022
The benefits and consequences of the COVID-19 pandemic for patients diagnosed with cancer and their family caregiversJennifer L Steel, Aarshati Amin, Tristen Peyser, et al.
Head & Neck|March 15, 2019
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavityDan P Zandberg, Luke J Tallon, Sushma Nagaraj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib TrialGlenn J Hanna, Dan P Zandberg, Deborah J Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2025
Phase I clinical trial of the bifunctional EGFR/TGF-β fusion protein ficerafusp alfa (BCA101) alone and in combination with pembrolizumab for advanced solid tumorsAlberto Hernando-Calvo, Richard D Carvajal, Paul K Paik, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Current Oncology (Toronto, Ont.)|October 27, 2023
Predictors and Consequences of Cancer and Non-Cancer-Related Pain in Those Diagnosed with Primary and Metastatic CancersKriti Shah, David A Geller, Samer Tohme, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 24, 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck SocietyKevin J Contrera, Sagar Kansara, Neerav Goyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid CancerMartina Chirra, Andrew Elliott, Hira Shaikh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck CancerDan P Zandberg, Lazar Vujanovic, David A Clump, et al.
Cancer Research Communications|March 2, 2023
Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay ValidationSophie Wildsmith, Jiabu Ye, April Franks, et al.
JCO Precision Oncology|November 20, 2024
CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A ReviewKevin J Contrera, Matthew E Spector, Liron Pantanowitz, et al.
Psycho-Oncology|January 27, 2022
The benefits and consequences of the COVID-19 pandemic for patients diagnosed with cancer and their family caregiversJennifer L Steel, Aarshati Amin, Tristen Peyser, et al.
Head & Neck|March 15, 2019
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavityDan P Zandberg, Luke J Tallon, Sushma Nagaraj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib TrialGlenn J Hanna, Dan P Zandberg, Deborah J Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2025
Phase I clinical trial of the bifunctional EGFR/TGF-β fusion protein ficerafusp alfa (BCA101) alone and in combination with pembrolizumab for advanced solid tumorsAlberto Hernando-Calvo, Richard D Carvajal, Paul K Paik, et al.
Pageof 10